Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 433, doi. 10.1002/cpdd.374
- By:
- Publication type:
- Article
Works matching IS 2160763X AND DT 2017 AND VI 6 AND IP 5
Results: 12
1
2
Pharmacokinetic and Bioequivalence Studies of a Newly Developed Branded Generic of Candesartan Cilexetil Tablets in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 492, doi. 10.1002/cpdd.321
- By:
- Publication type:
- Article
3
Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 484, doi. 10.1002/cpdd.329
- By:
- Publication type:
- Article
4
Effect of Food Intake on the Pharmacodynamics of Tenapanor: A Phase 1 Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 457, doi. 10.1002/cpdd.341
- By:
- Publication type:
- Article
5
Pharmacokinetics and Safety of DW1029M, a Botanical Drug for the Treatment of Diabetic Nephropathy, Following Single Doses in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 499, doi. 10.1002/cpdd.343
- By:
- Publication type:
- Article
6
Effects of Tenapanor on Cytochrome P450-Mediated Drug-Drug Interactions.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 466, doi. 10.1002/cpdd.346
- By:
- Publication type:
- Article
7
Luseogliflozin, an SGLT2 Inhibitor, in Japanese Patients With Mild/Moderate Hepatic Impairment: A Pharmacokinetic Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 439, doi. 10.1002/cpdd.364
- By:
- Publication type:
- Article
8
Effect of Food Intake on the Pharmacokinetics of a Novel Methylphenidate Extended-Release Oral Suspension for Attention Deficit Hyperactivity Disorder.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 476, doi. 10.1002/cpdd.366
- By:
- Publication type:
- Article
9
Bioequivalence Studies of a Reformulated Dutasteride and Tamsulosin Hydrochloride Combination Capsule and a Commercially Available Formulation.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 508, doi. 10.1002/cpdd.334
- By:
- Publication type:
- Article
10
Effect of Sustained Elevated Gastric pH Levels on Gefitinib Exposure.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 517, doi. 10.1002/cpdd.337
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 429, doi. 10.1002/cpdd.304
- Publication type:
- Article
12
Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.
- Published in:
- Clinical Pharmacology in Drug Development, 2017, v. 6, n. 5, p. 448, doi. 10.1002/cpdd.307
- By:
- Publication type:
- Article